BioStem Technologies is comprised of three divisions, each with a focus on different aspects of pharmaceutical and regenerative medicine, while maintaining a corporate and inter-divisional synergy of cost savings and cross pollination of experience and knowledge. From innovation in quality control to deep regulatory knowledge, the divisions hold much in common that can benefit the company—and the industry—as a whole.